Insider · CIK 0001872772

Wei Lin

Reports to the SEC for 4 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001872772

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-17	RVMDRevolution Medicines, Inc.S Sale	Chief Medical Officer	SSale	−2,073 sh	$99.48	−$206K	101,366
2026-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Medical Officer	AAward	+15.1K sh	—	—	103,439
2026-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+34K sh	—	—	34,000
2025-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Medical Officer	SSale	−2,160 sh	$45.82	−$99K	88,339
2025-06-16	RVMDRevolution Medicines, Inc.S Sale	Chief Medical Officer	SSale	−2,173 sh	$39.83	−$86.6K	90,499
2025-05-13	2seventy bio, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−17.6K sh	—	—	15,267
2025-05-13	2seventy bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−15.3K sh	—	—	0
2025-05-13	2seventy bio, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.1K sh	—	—	0
2025-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Medical Officer	AAward	−20.8K sh	—	—	91,651
2025-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+72.8K sh	—	—	72,800
2024-06-17	RVMDRevolution Medicines, Inc.S Sale	Chief Medical Officer	SSale	−5,589 sh	$37.39	−$209K	70,851
2024-06-10	2seventy bio, Inc.A Award	Director	AAward	+12.1K sh	—	—	32,850
2024-06-10	2seventy bio, Inc.Stock Options (Right to buy)A Award	Director	AAward	+24.1K sh	—	—	24,100
2023-06-13	2seventy bio, Inc.A Award	Director	AAward	+4,200 sh	—	—	20,800
2023-06-13	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,450 sh	—	—	8,450
2023-03-07	2seventy bio, Inc.A Award	Director	AAward	+16.6K sh	—	—	16,600
2023-03-07	2seventy bio, Inc.Stock Option (Right to buy)A Award	Director	AAward	+33.4K sh	—	—	33,400
2023-02-01	ERASErasca, Inc.J Other	Chief Medical Officer	JOther	+1,748 sh	$4.10	+$7,161.556	315,812
2023-02-01	ERASErasca, Inc.J Other	Chief Medical Officer	JOther	+2 sh	$3.89	+$7.786	315,812
2023-02-01	ERASErasca, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+560K sh	—	—	560,000
2022-02-01	ERASErasca, Inc.J Other	Chief Medical Officer	JOther	+1,562 sh	$11.60	+$18.1K	314,062
2022-02-01	ERASErasca, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+272K sh	—	—	272,100

Recent filings

Accepted (ET)
Mar 194
Wei Lin0001610717-26-000132
SEC(opens sec.gov)
Mar 34
Wei Lin0001610717-26-000084
SEC(opens sec.gov)
Sep 184
Wei Lin0001610717-25-000351
SEC(opens sec.gov)
Jun 184
Wei Lin0001610717-25-000237
SEC(opens sec.gov)
May 154
Wei Lin0001562180-25-003883
SEC(opens sec.gov)
Mar 44
Wei Lin0001610717-25-000052
SEC(opens sec.gov)
Jun 204
Wei Lin0001610717-24-000347
SEC(opens sec.gov)
Jun 124
Wei Lin0001562180-24-005009
SEC(opens sec.gov)
Jun 154
Wei Lin0001562180-23-005218
SEC(opens sec.gov)
Mar 94
Wei Lin0001562180-23-002688
SEC(opens sec.gov)
Feb 34
Wei Lin0001209191-23-006480
SEC(opens sec.gov)

Companies

Address

C/O TCGX ACQUISITION CORP. 245 LYTTON AVE., SUITE 350

PALO ALTO, CA, 94301